This study was undertaken to evaluate a novel method for stabilizing and preserving the original proportion of cell-free fetal DNA (cffDNA) in maternal blood for extended periods of time without using
Background: Cell free DNA (cfDNA) in plasma has received increasing attention and has been studied in a broad range of clinical conditions implicating inflammation, cancer, and aging. However, few stu
Additional file 12: Table S5. Comparison of biomarkers in APAP overdose patients before and after treatment with NAC Description of data: Total cfDNA was measured using a single-locus qPCR of the huma
